Chiara Alcantarini

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIV.

Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIV.

Journal: British journal of clinical pharmacology

Published: December 29, 2021

Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.

Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.

Journal: AIDS and behavior

Published: December 23, 2021

The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries.

The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries.

Journal: Microorganisms

Published: June 07, 2021

Medication burden and clustering in people living with HIV undergoing therapeutic drug monitoring.

Medication burden and clustering in people living with HIV undergoing therapeutic drug monitoring.

Journal: British journal of clinical pharmacology

Published: February 03, 2021

Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV.

Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV.

Journal: Clinical pharmacokinetics

Published: August 02, 2020

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection.

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection.

Journal: Thrombosis research

Published: July 09, 2020

Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study.

Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study.

Journal: CNS spectrums

Published: May 28, 2019

Sustained virological response with 16-week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post-transplant severe HCV recurrence in HIV.

Sustained virological response with 16-week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post-transplant severe HCV recurrence in HIV.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: May 05, 2019

Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders.

Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders.

Journal: HIV medicine

Published: March 23, 2018

The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment.

The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment.

Journal: Antiviral therapy

Published: January 10, 2018

Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid.

Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid.

Journal: The Journal of antimicrobial chemotherapy

Published: December 16, 2017

Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairment.

Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairment.

Journal: AIDS (London, England)

Published: December 05, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026